CV Accueil - Archive ouverte HAL

	Investigation of alendronate-doped Apatitic Cements as a Potential Technology for the Prevention of Osteoporotic Hip Fractures: Critical Influence of the Drug Introduction Mode on the In Vitro Cement Properties. V. Schnitzler , F. Fayon , C. Despas , I. Khairoun , C. Mellier Acta Biomaterialia, 2011, 7, pp.759-770. ⟨10.1016/j.actbio.2010.09.017⟩ Article dans une revue hal-00608513v1

	Alendronate-doped Apatitic Cements as a Potential Technology for the Prevention of Osteoporotic Hip Fractures V. Schnitzler , F. Fayon , C. Despas , I. Khairoun , T. Rouillon E-MRS spring meeting 2010, Jun 2010, Strasbourg, France Communication dans un congrès hal-00640846v1

Gilles Montavon